Publication

Consumo de productos alimentarios ultraprocesados y procesados con exceso de nutrientes asociados a las enfermedades crónicas no transmisibles y a la alimentación insalubre en las Américas
PAHO report 2021; OPS/NMH/RF/21-0036

Available here

Enhanced surveillance of hospitalised COVID-19 patients in Europe: I-MOVE-COVID-19 surveillance network, February 2020 to December 2021

Mutch H, Young JJ, Sadiq F, Rose AMC, Evans JMM, on behalf of the European COVID-19 hospital surveillance analysis writing group

Euro Surveill. 2023;28(26):pii=2200669

Available here

Enhanced surveillance of hospitalized COVID-19 patients in Europe: an evaluation of the I-MOVE-COVID-19 surveillance network, European Journal of Public Health, 2023

Johanna J Young, Heather Mutch, Angela M C Rose, Josie M M Evans, the European COVID-19 Hospital Evaluation Writing Group

ckad185

Available here

Prévention de la coqueluche chez le nouveau-né : faut-il vacciner les femmes enceintes à chaque grossesse ?

Niaré D, Debin M, Merdrignac L, Blanchon T, Hanslik T, Steichen O,

Rev Med Interne, 2023, ISSN 0248-8663, https://doi.org/10.1016/j.revmed.2023.06.007

Available here

Relative vaccine effectiveness against COVID-19 hospitalisation in persons aged ≥ 65 years: results from a VEBIS network, Europe, October 2021 to July 2023

Fontán-Vela Mario, Kissling Esther, Nicolay Nathalie, Braeye Toon, Van Evercooren Izaak, Holm Hansen Christian, Emborg Hanne-Dorthe, Fabiani Massimo, Mateo-Urdiales Alberto, AlKerwi Ala’a, Schmitz Susanne, Castilla Jesús, Martínez-Baz Iván, de Gier Brechje, Hahné Susan, Meijerink Hinta, Starrfelt Jostein, Nunes Baltazar, Caetano Constantino, Derrough Tarik, Nardone Anthony, Monge Susana, VEBIS-Lot4 working group.

Euro Surveill. 2024;29(1):pii=2300670

Available here

Influenza vaccine effectiveness in Europe: Results from the 2022–2023 VEBIS (Vaccine Effectiveness, Burden and Impact Studies) primary care multicentre study

Maurel M, Pozo F, Pérez-Gimeno G, et al.

Influenza Other Respi Viruses. 2024; 18(1):e13243. doi:10.1111/irv.13243

Available here

A pilot sentinel surveillance system to monitor treatment and treatment outcomes of chronic hepatitis B and C infections in clinical centres in three European countries, 2019

Nardone A, Nerlander L, Duffell E, Valenciano M, Buti M, Marcos-Fosch C, Nemeth-Blažić T, Popovici O, Vince A, Filip PV, Filipec T, Kosanović Ličina ML, Luksic B, Nonković D, Pop CS, Radu F, Teodorescu I, Topan AV.

Euro Surveill. 2023 Feb;28(6):2200184. doi: 10.2807/1560-7917.ES.2023.28.6.2200184. PMID: 36757314; PMCID: PMC9912376

Available here

Evolution of seroprevalence to SARS-CoV-2 in blood donors in Sarajevo Canton, Federation of Bosnia and Herzegovina: Cross-sectional and longitudinal studies

Musa S, Catovic Baralija E, Ivey Sawin V, Nardone A, Palo M, Skocibusic S, Blazevic M, Cilovic Lagarija S, Ahmetovic-Karic G, Ljuca A, Dostovic-Halilovic S, Nedic R, Subissi L, Ibrahim R, Boshevska G, Bergeri I, Pebody R, Vaughan A.

Influenza Other Respir Viruses. 2023 Aug 22;17(8):e13182. doi: 10.1111/irv.13182. PMID: 37621919; PMCID: PMC10444603.

Available here

Systematic review of seroprevalence of SARS-CoV-2 antibodies and appraisal of evidence, prior to the widespread introduction of vaccine programmes in the WHO European Region, January-December 2020

Vaughan A, Duffell E, Freidl GS, Lemos DS, Nardone A, Valenciano M, Subissi L, Bergeri I, K Broberg E, Penttinen P, Pebody R, Keramarou M.

BMJ Open. 2023 Nov 6;13(11):e064240. doi: 10.1136/bmjopen-2022-064240. PMID: 37931969; PMCID: PMC10632881.

Available here

Vaccine effectiveness against COVID-19 hospitalisation in adults (≥ 20 years) during Omicron-dominant circulation: I-MOVE-COVID-19 and VEBIS SARI VE networks, Europe, 2021 to 2022

Rose AM, Nicolay N, Sandonis Martín V, Mazagatos C, Petrović G, Baruch J, Denayer S, Seyler L, Domegan L, Launay O, Machado A, Burgui C, Vaikutyte R, Niessen FA, Loghin II, Husa P, Aouali N, Panagiotakopoulos G, Tolksdorf K, Horváth JK, Howard J, Pozo F, Gallardo V, Nonković D, Džiugytė A, Bossuyt N, Demuyser T, Duffy R, Luong Nguyen LB, Kislaya I, Martínez-Baz I, Gefenaite G, Knol MJ, Popescu C, Součková L, Simon M, Michelaki S, Reiche J, Ferenczi A, Delgado-Sanz C, Lovrić Makarić Z, Cauchi JP, Barbezange C, Van Nedervelde E, O’Donnell J, Durier C, Guiomar R, Castilla J, Jonikaite I, Bruijning-Verhagen PC, Lazar M, Demlová R, Wirtz G, Amerali M, Dürrwald R, Kunstár MP, Kissling E, Bacci S, Valenciano M; I-MOVE-COVID-19 hospital study team; VEBIS hospital study team; Members of the I-MOVE-COVID-19 and VEBIS hospital study teams (in addition to authors above)

Euro Surveill. 2023 Nov;28(47):2300187. doi: 10.2807/1560-7917.ES.2023.28.47.2300187. PMID: 37997665; PMCID: PMC10668256.

Available here

Référencement Centrales d'achats

Hébergement de données de santé

Nous sommes Hébergeur de Données de Santé (HDS) à caractère personnel depuis 2012 avec la certification ISO 27001/HDS depuis 2019.

En savoir plus

Engagements et éthique

Epiconcept s’engage sur des relations éthiques auprès de ses parties prenantes. Découvrez nos engagements dans notre charte.

En savoir plus

Satisfaction collaborateurs

91,7% de nos collaborateurs recommandent Epiconcept à un(e) ami(e) pour venir y travailler !

En savoir plus